FDASRA Act of 2022

United States117th CongressS-4535Senate
Updated: Jul 14, 2022

Summary

Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022 This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

  2. Introduced in Senate

All available records shown.